MediBeacon(R) Next Generation TGFR(TM) System Receives FDA Approval
MediBeacon(R) TGFR(TM) System is a first-in-kind product for point of care kidney function assessment Centers of Excellence commercialization in select academic medical centers begins in early 2026 ST. LOUIS, Dec. 16, 2025 (GLOBE NEWSWIRE) — MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced […]